STAT3 and glioblastoma: Application of the STAT3-associated pathway inhibitor pacritinib reduced the release of miR-21-containing exosomes from TAMs as well as cell viability and colony formation associated with reduced levels of STAT3, Sox2, PDCD4, and miR-21 in GBM cells.